Quadrille Capital
Venture Capital
Active
Paris, France
47
73M
30
2.04
3
0.36
9
- Stages of investment
- Areas of investment
Summary
Quadrille Capital appeared to be the VC, which was created in 2007. The main office of represented VC is situated in the Paris. The company was established in Europe in France.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Quadrille Capital, startups are often financed by Norwest Venture Partners, Venrock, Windham Venture Partners. The meaningful sponsors for the fund in investment in the same round are Windham Venture Partners, Universal Music Group, Tudor Investments. In the next rounds fund is usually obtained by New Enterprise Associates, Windham Venture Partners, TPG Growth.
We also calculated 4 valuable employees in our database.
The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Intarcia Therapeutics, ezCater, Neotract. We can highlight the next thriving fund investment areas, such as Marketing, Manufacturing.
The high activity for fund was in 2019. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. This Quadrille Capital works on 6 percentage points less the average amount of lead investments comparing to the other organizations. The average startup value when the investment from Quadrille Capital is more than 1 billion dollars. Considering the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- EUR 511000000
- Fund raised date
- 2021-03-04
Analytics
- Total investments
- 47
- Lead investments
- 3
- Exits
- 9
- Rounds per year
- 2.04
- Follow on index
- 0.36
- Investments by industry
- Health Care (13)
- E-Commerce (9)
- Medical (9)
- Medical Device (9)
- Biotechnology (8) Show 79 more
- Investments by region
-
- United States (26)
- Spain (2)
- Czechia (2)
- France (5)
- China (2) Show 6 more
- Peak activity year
- 2021
- Number of Unicorns
- 6
- Number of Decacorns
- 6
- Number of Minotaurs
- 3
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 531M
- Group Appearance index
- 0.89
- Avg. company exit year
- 10
- Avg. multiplicator
- 3.89
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Computational Life | 30 Oct 2020 | Software, Health Diagnostics, Medical Device, Medical, Simulation | Seed | 250K | Italy, Friuli-Venezia Giulia |
Medwing | 15 Mar 2023 | Human Resources, Recruiting, Health Care | Late Stage Venture | 51M | Berlin, Berlin, Germany |
Neotract | 15 Sep 2009 | Biotechnology, Health Care, Medical Device, Medical | Early Stage Venture | 28M | United States, California, Mountain View |
The Transformation Factory | 23 May 2022 | Health Care, Personal Health, Dietary Supplements | Seed | 600K | United States, Florida, Lake Worth |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.